Xia et al. demonstrated that Cry2 suppresses the proliferation of breast cancer cells by repressing genes within the NF-κB pathway, whereas its acetylation attenuates this inhibitory effect [21]. This evidence concerns the gene CRY2 and breast carcinoma.